SBFM stock

Companies

Market cap of Sunshine Biopharma Inc [SBFM] reaches 6.02M – now what?

Sunshine Biopharma Inc [NASDAQ: SBFM] gained 6.14% on the last trading session, reaching $0.06 price per share at the time. The company report on February 15, 2024 at 9:15 AM that Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering. Sunshine Biopharma, Inc.

HAPP Stock
Industry

Sunshine Biopharma Inc [SBFM] moved down -1.37: Why It’s Important

Sunshine Biopharma Inc [NASDAQ: SBFM] closed the trading session at $0.06. The company report on February 15, 2024 at 9:15 AM that Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering. Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the “Company”), a pharmaceutical company offering and researching

CTVA
Companies

Sunshine Biopharma Inc [SBFM] fell -79.59% so far this year. What now?

Sunshine Biopharma Inc [NASDAQ: SBFM] price plunged by 0.00 percent to reach at $0.0. The company report on February 15, 2024 at 9:15 AM that Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering. Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the “Company”), a pharmaceutical company

TTWO
Industry

Market cap of Sunshine Biopharma Inc [SBFM] reaches 3.06M – now what?

Sunshine Biopharma Inc [NASDAQ: SBFM] closed the trading session at $0.06. The company report on February 15, 2024 at 9:15 AM that Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering. Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the “Company”), a pharmaceutical company offering and researching

Market

Sunshine Biopharma Inc [SBFM] fell -74.66% so far this year. What now?

Sunshine Biopharma Inc [NASDAQ: SBFM] price plunged by -63.83 percent to reach at -$0.12. The company report on February 13, 2024 at 9:00 AM that Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering. Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the “Company”), a pharmaceutical company